{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:42:31Z","timestamp":1790854951040,"version":"4.1.0"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T00:00:00Z","timestamp":1307059200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0020696","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T16:53:46Z","timestamp":1307120026000},"page":"e20696","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":99,"title":["Hdac6 Knock-Out Increases Tubulin Acetylation but Does Not Modify Disease Progression in the R6\/2 Mouse Model of Huntington's Disease"],"prefix":"10.1371","volume":"6","author":[{"given":"Anna","family":"Bobrowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Paganetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Matthias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian P.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,6,3]]},"reference":[{"key":"ref1","first-page":"xvi","article-title":"Huntington&apos;s disease","author":"G Bates","year":"2002"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"c3109","DOI":"10.1136\/bmj.c3109","article-title":"Huntington&apos;s disease.","volume":"340","author":"MJ Novak","year":"2010","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington&apos;s disease chromosomes.","volume":"72","year":"1993","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington&apos;s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.","volume":"8","author":"SJ Tabrizi","year":"2009","journal-title":"The Lancet Neurology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington&apos;s disease in the TRACK-HD study: the 12-month longitudinal analysis.","volume":"10","author":"SJ Tabrizi","year":"2011","journal-title":"The Lancet Neurology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.","volume":"277","author":"M DiFiglia","year":"1997","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","article-title":"Molecular mechanisms and potential therapeutical targets in Huntington&apos;s disease.","volume":"90","author":"C Zuccato","year":"2010","journal-title":"Physiol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nrn1989","article-title":"Histone deacetylase inhibitors as therapeutics for polyglutamine disorders.","volume":"7","author":"R Butler","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family.","volume":"370","author":"AJ de Ruijter","year":"2003","journal-title":"Biochem J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nature08197","article-title":"Recent progress in the biology and physiology of sirtuins.","volume":"460","author":"T Finkel","year":"2009","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1523\/JNEUROSCI.3344-05.2006","article-title":"Differential contributions of Caenorhabditis elegans histone deacetylases to Huntingtin polyglutamine toxicity.","volume":"26","author":"EA Bates","year":"2006","journal-title":"Journal of Neuroscience"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington&apos;s disease.","volume":"100","author":"E Hockly","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.","volume":"413","author":"JS Steffan","year":"2001","journal-title":"Nature"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","article-title":"Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington&apos;s disease.","volume":"17","author":"J Pallos","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/BJ20070779","article-title":"Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.","volume":"409","author":"N Khan","year":"2008","journal-title":"Biochem J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1073\/pnas.96.9.4868","article-title":"Three proteins define a class of human histone deacetylases related to yeast Hda1p.","volume":"96","author":"CM Grozinger","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"8035","DOI":"10.1128\/MCB.21.23.8035-8044.2001","article-title":"Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways.","volume":"21","author":"D Seigneurin-Berny","year":"2001","journal-title":"Mol Cell Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/emboj\/cdg115","article-title":"HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo.","volume":"22","author":"Y Zhang","year":"2003","journal-title":"EMBO J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase.","volume":"417","author":"C Hubbert","year":"2002","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor.","volume":"18","author":"JJ Kovacs","year":"2005","journal-title":"Mol Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.molcel.2007.05.033","article-title":"HDAC6 modulates cell motility by altering the acetylation level of cortactin.","volume":"27","author":"X Zhang","year":"2007","journal-title":"Mol Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0962-8924(00)01852-3","article-title":"Aggresomes, inclusion bodies and protein aggregation.","volume":"10","author":"RR Kopito","year":"2000","journal-title":"Trends in Cell Biology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","article-title":"The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress.","volume":"115","author":"Y Kawaguchi","year":"2003","journal-title":"Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1101\/gad.461107","article-title":"The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response.","volume":"21","author":"S Kwon","year":"2007","journal-title":"Genes Dev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"40282","DOI":"10.1074\/jbc.M508786200","article-title":"HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin.","volume":"280","author":"A Iwata","year":"2005","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nature05853","article-title":"HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.","volume":"447","author":"UB Pandey","year":"2007","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/emboj.2009.405","article-title":"HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy.","volume":"29","author":"JY Lee","year":"2010","journal-title":"EMBO J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.0037-07.2007","article-title":"Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington&apos;s disease by increasing tubulin acetylation.","volume":"27","author":"JP Dompierre","year":"2007","journal-title":"J Neurosci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000056967","article-title":"Assignment of the human histone deacetylase 6 gene (HDAC6) to X chromosome p11.23 by in situ hybridization.","volume":"93","author":"U Mahlknecht","year":"2001","journal-title":"Cytogenet Cell Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.","volume":"87","author":"L Mangiarini","year":"1996","journal-title":"Cell"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e8025","DOI":"10.1371\/journal.pone.0008025","article-title":"Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington&apos;s disease.","volume":"4","author":"H Moffitt","year":"2009","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","article-title":"Proteolysis of Mutant Huntingtin Produces an Exon 1 Fragment That Accumulates as an Aggregated Protein in Neuronal Nuclei in Huntington Disease.","volume":"285","author":"C Landles","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes.","volume":"72","author":"B Woodman","year":"2007","journal-title":"Brain Res Bull"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/hmg\/ddp467","article-title":"Identical oligomeric and fibrillar structures captured from the brains of R6\/2 and knock-in mouse models of Huntington&apos;s disease.","volume":"19","author":"K Sathasivam","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin&apos;s effects on striatal gene expression in mice recapitulate changes observed in human Huntington&apos;s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.","volume":"16","author":"A Kuhn","year":"2007","journal-title":"Human Molecular Genetics"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/MCB.01154-06","article-title":"Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally.","volume":"28","author":"Y Zhang","year":"2008","journal-title":"Mol Cell Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain.","volume":"11","author":"R Luthi-Carter","year":"2002","journal-title":"Human Molecular Genetics"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1128\/MCB.00393-07","article-title":"Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis.","volume":"27","author":"YS Gao","year":"2007","journal-title":"Mol Cell Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.cub.2006.09.014","article-title":"Microtubule acetylation promotes kinesin-1 binding and transport.","volume":"16","author":"NA Reed","year":"2006","journal-title":"Curr Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.","volume":"118","author":"LR Gauthier","year":"2004","journal-title":"Cell"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases.","volume":"5","author":"C Zuccato","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain.","volume":"389","author":"CA Altar","year":"1997","journal-title":"Nature"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington&apos;s Disease: Can Mice Lead the Way to Treatment?","volume":"69","author":"ZR Crook","year":"2011","journal-title":"Neuron"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/(SICI)1096-9861(19990125)403:4<421::AID-CNE1>3.0.CO;2-5","article-title":"Analysis of Huntingtin-associated protein 1 in mouse brain and immortalized striatal neurons.","volume":"403","author":"EJ Martin","year":"1999","journal-title":"J Comp Neurol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mcn.2008.04.007","article-title":"CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6\/2 mice.","volume":"39","author":"BL Apostol","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"ref46","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1182","article-title":"Rescuing the Corticostriatal Synaptic Disconnection in the R6\/2 Mouse Model of Huntington&apos;s Disease: Exercise, Adenosine Receptors and Ampakines.","volume":"2","author":"C Cepeda","year":"2010","journal-title":"PLoS Curr"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/hmg\/ddn211","article-title":"Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II\/III in YAC72 and R6\/2 transgenic mice partially model Huntington&apos;s disease patients.","volume":"17","author":"H Seo","year":"2008","journal-title":"Hum Mol Genet"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1172\/JCI31778","article-title":"Induction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington disease.","volume":"117","author":"S-R Cho","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington&apos;s disease.","volume":"24","author":"JM Canals","year":"2004","journal-title":"J Neurosci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington&apos;s disease phenotypes in mice.","volume":"105","author":"K Gharami","year":"2008","journal-title":"J Neurochem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1091\/mbc.E10-03-0200","article-title":"Drosophila histone deacetylase 6 protects dopaminergic neurons against {alpha}-synuclein toxicity by promoting inclusion formation.","volume":"21","author":"G Du","year":"2010","journal-title":"Mol Biol Cell"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4161\/auto.5050","article-title":"HDAC6 at the intersection of autophagy, the ubiquitin-proteasome system and neurodegeneration.","volume":"3","author":"UB Pandey","year":"2007","journal-title":"Autophagy"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/j.1471-4159.2008.05564.x","article-title":"Histone deacetylase 6 interacts with the microtubule-associated protein tau.","volume":"106","author":"H Ding","year":"2008","journal-title":"J Neurochem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e5747","DOI":"10.1371\/journal.pone.0005747","article-title":"Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6\/2 mouse model of Huntington&apos;s disease.","volume":"4","author":"CL Benn","year":"2009","journal-title":"PLoS One"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0361-9230(03)00185-0","article-title":"Standardization and statistical approaches to therapeutic trials in the R6\/2 mouse.","volume":"61","author":"E Hockly","year":"2003","journal-title":"Brain Res Bull"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.nbd.2005.07.007","article-title":"Evaluation of the benzothiazole aggregation inhibitors riluzole and PGL-135 as therapeutics for Huntington&apos;s disease.","volume":"21","author":"E Hockly","year":"2006","journal-title":"Neurobiol Dis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/hmg\/10.21.2425","article-title":"Centrosome disorganization in fibroblast cultures derived from R6\/2 Huntington&apos;s disease (HD) transgenic mice and HD patients.","volume":"10","author":"K Sathasivam","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0361-9230(01)00599-8","article-title":"New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins.","volume":"56","author":"J Ko","year":"2001","journal-title":"Brain Research Bulletin"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1326-4-11","article-title":"Inducible mutant huntingtin expression in HN10 cells reproduces Huntington&apos;s disease-like neuronal dysfunction.","volume":"4","author":"A Weiss","year":"2009","journal-title":"Mol Neurodegener"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ab.2009.08.001","article-title":"Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington&apos;s disease.","volume":"395","author":"A Weiss","year":"2009","journal-title":"Anal Biochem"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneumeth.2004.03.026","article-title":"Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.","volume":"140","author":"ME Szapacs","year":"2004","journal-title":"Journal of Neuroscience Methods"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1326-3-17","article-title":"Optimisation of region-specific reference gene selection and relative gene expression analysis methods for pre-clinical trials of Huntington&apos;s disease.","volume":"3","author":"CL Benn","year":"2008","journal-title":"Mol Neurodegener"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0020696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T01:58:24Z","timestamp":1540346304000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0020696"}},"subtitle":[],"editor":[{"given":"Koichi M.","family":"Iijima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,3]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0020696","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,3]]}}}